Rescula

Active Ingredient(s): Unoprostone
FDA Approved: * August 3, 2000
Pharm Company: * R TECH UENO LTD
Category: Vision / Eye Health

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Rescula Overview

Unoprostone (INN) is a prostaglandin analogue. Its isopropyl ester, unoprostone isopropyl, was marketed under the trade name Rescula for the management of open-angle glaucoma and ocular hypertension.[1] It was approved by the Food and Drug Administration in 2000.[2] In 2009, Sucampo Pharmaceuticals acquired the rights to the drug in the U.S. and Canada.[3] In 2015, the drug was discontinued in the U.S. References ^ Micromedex Detailed Consu...

Read more Rescula Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Unoprostone

Recent Rescula Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Unoprostone
  • Solution: 0.15%
  • Solution/drops: 0.15%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rescula: (1 result)

Sorted by National Drug Code
  • 17350-015 Rescula 1.5 mg/ml Ophthalmic Solution/ Drops by Sucampo Pharma Americas, LLC

Other drugs which contain Unoprostone or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 24 November 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA